Nuvation Bio Inc - Ordinary Shares - Class A

Nuvation Bio Inc - Ordinary Shares - Class A

NUVB

Market Cap$709.06M
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Nuvation Bio Inc - Ordinary Shares - Class ANuvation Bio Inc - Ordinary Shares - Class A-1.2--145%-0.1
$6.00

Target Price by Analysts

187.1% upsideNuvation Bio Target Price DetailsTarget Price
$0.30

Current Fair Value

85.8% downside

Overvalued by 85.8% based on the discounted cash flow analysis.

Share Statistics

Market cap$709.06 Million
Enterprise Value$683.03 Million
Dividend Yield$0 (0%)
Earnings per Share$-2.11
Beta1.37
Outstanding Shares338,612,000

Return

Return on Equity-
Return on Assets-
Return on Invested Capital-

Valuation & Multiples

P/E Ratio-1.17
PEG-0.45
Price to Sales-
Price to Book Ratio2.09
Enterprise Value to Revenue62.34
Enterprise Value to EBIT-3.39
Enterprise Value to Net Income-2
Total Debt to Enterprise0.03
Debt to Equity0.05

Revenue Sources

No data

Insider Trades

ESG Score

No data

About Nuvation Bio Inc

36 employees

Nuvation Bio is a biopharmaceutical company tackling some of the greatest unmet needs in oncology by developing differentiated and novel therapeutic candidates. Nuvation Bio's proprietary portfolio includes six novel and mechanistically ...